Sort   by:  
 Page size 
UnknownBasePhasing: a highly efficient approach for preimplantation genetic haplotyping in clinical application of balanced translocation carriers.
Not available
S-EPMC6423798 | biostudies-literature
UnknownIdentification of siRNA silencing TGFβ1 and VEGFR2 and utility of the combination in targeting immune modulation and angiogenesis in treating melanoma <i>in vivo</i>.
Not available
S-EPMC12813501 | biostudies-literature
UnknownThe role of transcriptomic biomarkers of endometrial receptivity in personalized embryo transfer for patients with repeated implantation failure.
Not available
S-EPMC8082865 | biostudies-literature
UnknownCan biomarkers identified from the uterine fluid transcriptome be used to establish a noninvasive endometrial receptivity prediction tool? A proof-of-concept study.
Not available
S-EPMC9938621 | biostudies-literature
UnknownNoninvasive fetal genotyping of single nucleotide variants and linkage analysis for prenatal diagnosis of monogenic disorders.
Not available
S-EPMC9327225 | biostudies-literature
UnknownPreclinical development of HQP1351, a multikinase inhibitor targeting a broad spectrum of mutant KIT kinases, for the treatment of imatinib-resistant gastrointestinal stromal tumors.
Not available
S-EPMC6815454 | biostudies-literature
UnknownComparison of the predictive power of novel insulin resistance, lipid metabolism and obesity indices for the risk of developing dyslipidaemia in adults.
Not available
S-EPMC12922431 | biostudies-literature
UnknownBasiliximab in the Prophylaxis of aGVHD for Unrelated Donor Hematopoietic Stem Cell Transplantation in Patients With Thalassemia Major: A Prospective, Multicenter, Open-Label, Randomized Controlled Study.
Not available
S-EPMC12868989 | biostudies-literature
UnknownAssociation Between Urinary Metal Levels and Chronic Kidney Dysfunction in Rural China: A Study on Sex-Specific Differences.
Not available
S-EPMC11768882 | biostudies-literature
UnknownOlverembatinib (HQP1351), a well-tolerated and effective tyrosine kinase inhibitor for patients with T315I-mutated chronic myeloid leukemia: results of an open-label, multicenter phase 1/2 trial.
Not available
S-EPMC9389804 | biostudies-literature
Sort   by:  
 Page size